Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Rahman NM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 24
Tytuł:
Assessment of Ventilatory Heterogeneity in Chronic Obstructive Pulmonary Disease Using the Inspired Sinewave Test
Autorzy:
Bruce RM
Phan PA
Rigolli M
Tran MC
Pacpaco E
Rahman NM
Farmery AD
Pokaż więcej
Temat:
copd
lung function test
nitrous oxide
medical device
ventilatory heterogeneity
Diseases of the respiratory system
RC705-779
Źródło:
International Journal of COPD, Vol Volume 16, Pp 401-413 (2021)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/assessment-of-ventilatory-heterogeneity-in-chronic-obstructive-pulmona-peer-reviewed-article-COPD; https://doaj.org/toc/1178-2005
Dostęp URL:
https://doaj.org/article/de4246b0014b4e67a436ce4157f8b2c8  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Lung Ultrasound Reproducibly Outperforms Computed Tomography in the Detection of Extravascular Lung Water in Patients Undergoing Haemodialysis.
Autorzy:
Corcoran JP; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.; Oxford Respiratory Trials Unit, University of Oxford, Oxford OX3 7LE, UK.
Hew M; Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, VIC 3004, Australia.; School of Public Health & Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
Attwood B; Department of Anaesthesia and Intensive Care, South Warwickshire NHS Foundation Trust, Warwick CV34 5BW, UK.
Shyamsundar M; Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT7 1NN, UK.
Sutherland S; Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Ventura K; Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Benamore R; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
St Noble V; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Piotrowska HE; Oxford Respiratory Trials Unit, University of Oxford, Oxford OX3 7LE, UK.
Pugh CW; Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LE, UK.
Laursen CB; Department of Respiratory Medicine, Odense University Hospital, 5000 Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
Gleeson FV; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7LE, UK.
Rahman NM; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.; Oxford Respiratory Trials Unit, University of Oxford, Oxford OX3 7LE, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7LE, UK.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Mar 11; Vol. 14 (6). Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Malignant pleural effusion: current understanding and therapeutic approach.
Autorzy:
Gonnelli F; Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona Via Conca 71, Ancona, 60126, Italy.
Hassan W; Department of Respiratory Medicine, Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK.
Bonifazi M; Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona Via Conca 71, Ancona, 60126, Italy.
Pinelli V; Pulmonology Unit, San Bartolomeo Hospital, Sarzana, Italy.
Bedawi EO; Department of Respiratory Medicine, Sheffield Teaching Hospitals, University of Sheffield, Sheffield, UK.
Porcel JM; Research Group of Cancer Biomarkers, Lleida Institute for Biomedical Research Dr. Pifarré Foundation (IRBLleida), Lleida, Spain.; Pleural Medicine and Clinical Ultrasound Unit, Department of Internal Medicine, Arnau de Vilanova, University Hospital, Lleida, Spain.
Rahman NM; Oxford Pleural Unit, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.; Oxford NIHR Biomedical Research Unit, Oxford, UK.; Chinese Academy of Medicine Oxford Institute, Oxford, UK.
Mei F; Department of Biomedical Sciences and Public Health, Università Politecnica delle Marche, Ancona Via Conca 71, Ancona, 60126, Italy. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2024 Jan 19; Vol. 25 (1), pp. 47. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pleural Effusion, Malignant*/diagnosis
Pleural Effusion, Malignant*/therapy
Humans ; Pleurodesis ; Talc ; Catheters, Indwelling ; Drainage/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology.
Autorzy:
Bibby AC; Academic Respiratory Unit, University of Bristol Medical School, Bristol, UK. .; North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK. .
Zahan-Evans N; North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK.
Keenan E; North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK.
Comins C; Bristol Haematology & Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Harvey JE; Academic Respiratory Unit, University of Bristol Medical School, Bristol, UK.
Day H; Academic Respiratory Unit, University of Bristol Medical School, Bristol, UK.
Rahman NM; Oxford Respiratory Trials Unit, Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK.
Fallon JE; Respiratory Department, Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, UK.
Gooberman-Hill R; NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, UK.
Maskell NA; Academic Respiratory Unit, University of Bristol Medical School, Bristol, UK.; North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK.
Pokaż więcej
Źródło:
Pilot and feasibility studies [Pilot Feasibility Stud] 2022 Sep 03; Vol. 8 (1), pp. 196. Date of Electronic Publication: 2022 Sep 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pneumothorax management: current state of practice in the UK.
Autorzy:
Hallifax RJ; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK. .; Oxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Oxford, UK. .
Roberts M; Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, UK.
Russell N; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.
Laskawiec-Szkonter M; Oxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Oxford, UK.
Walker SP; Academic Respiratory Unit Bristol, University of Bristol, Bristol, UK.
Maskell NA; Academic Respiratory Unit Bristol, University of Bristol, Bristol, UK.
Rahman NM; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; Oxford Respiratory Trials Unit, University of Oxford, Churchill Hospital, Oxford, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2022 Feb 07; Vol. 23 (1), pp. 23. Date of Electronic Publication: 2022 Feb 07.
Typ publikacji:
Letter
MeSH Terms:
Chest Tubes*
Drainage/*methods
Pneumothorax/*therapy
Humans ; Incidence ; Pneumothorax/epidemiology ; United Kingdom/epidemiology
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Management of Pleural Infection.
Autorzy:
Sundaralingam A; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. .
Banka R; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Rahman NM; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford Respiratory Trials Unit, University of Oxford, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford, UK.
Pokaż więcej
Źródło:
Pulmonary therapy [Pulm Ther] 2021 Jun; Vol. 7 (1), pp. 59-74. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Diagnostics in Pleural Disease.
Autorzy:
Sundaralingam A; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
Bedawi EO; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.; Oxford Respiratory Trials Unit, University of Oxford, Oxford OX3 7LE, UK.
Rahman NM; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.; Oxford Respiratory Trials Unit, University of Oxford, Oxford OX3 7LE, UK.; Oxford NIHR Biomedical Research Centre, Oxford OX4 2PG, UK.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2020 Dec 04; Vol. 10 (12). Date of Electronic Publication: 2020 Dec 04.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial.
Autorzy:
Hinks TSC; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine Experimental Medicine, University of Oxford, Oxfordshire, OX3 9DU, UK. .
Barber VS; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK.
Black J; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK.
Dutton SJ; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK.
Jabeen M; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine Experimental Medicine, University of Oxford, Oxfordshire, OX3 9DU, UK.
Melhorn J; University Hospital Llandough, Cardiff, CF64 2XX, UK.
Rahman NM; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine Experimental Medicine, University of Oxford, Oxfordshire, OX3 9DU, UK.
Richards D; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, UK.
Lasserson D; Nuffield Department of Medicine, Oxford University, Oxford, UK.; Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Pavord ID; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine Experimental Medicine, University of Oxford, Oxfordshire, OX3 9DU, UK.
Bafadhel M; Respiratory Medicine Unit and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Nuffield Department of Medicine Experimental Medicine, University of Oxford, Oxfordshire, OX3 9DU, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2020 Aug 17; Vol. 21 (1), pp. 718. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Anti-Bacterial Agents*/therapeutic use
Azithromycin*/therapeutic use
COVID-19*/diagnosis
COVID-19 Drug Treatment*
Humans ; Prospective Studies ; Randomized Controlled Trials as Topic ; Research Design ; SARS-CoV-2 ; Severity of Illness Index ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Ambulatory Care/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pleural Pressure Pulse in Patients with Pleural Effusion: A New Phenomenon Registered during Thoracentesis with Pleural Manometry.
Autorzy:
Grabczak EM; Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
Michnikowski M; Nalecz Institute of Biocybernetics and Biomedical Engineering, Ksiecia Trojdena 4, 02-109 Warsaw, Poland.
Styczynski G; Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
Zielinska-Krawczyk M; Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
Stecka AM; Nalecz Institute of Biocybernetics and Biomedical Engineering, Ksiecia Trojdena 4, 02-109 Warsaw, Poland.
Korczynski P; Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
Zielinski K; Nalecz Institute of Biocybernetics and Biomedical Engineering, Ksiecia Trojdena 4, 02-109 Warsaw, Poland.
Palko KJ; Nalecz Institute of Biocybernetics and Biomedical Engineering, Ksiecia Trojdena 4, 02-109 Warsaw, Poland.
Rahman NM; Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford University Hospitals NHS Foundation Trust, Headley Way, Headington, Oxford OX3 9DU, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 9DU, UK.
Golczewski T; Nalecz Institute of Biocybernetics and Biomedical Engineering, Ksiecia Trojdena 4, 02-109 Warsaw, Poland.
Krenke R; Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Jul 27; Vol. 9 (8). Date of Electronic Publication: 2020 Jul 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Microbiome profile associated with malignant pleural effusion.
Autorzy:
Shojaee S; Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, United States of America.
Sharma A; Department of Pediatrics, University of California San Diego School of Medicine, San Diego, CA, United States of America.
Gottel N; Department of Pediatrics, University of California San Diego School of Medicine, San Diego, CA, United States of America.; Scripps Institution of Oceanography, UCSD, San Diego, CA, United States of America.
Sanchez T; Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, United States of America.
Gilbert JA; Department of Pediatrics, University of California San Diego School of Medicine, San Diego, CA, United States of America.; Scripps Institution of Oceanography, UCSD, San Diego, CA, United States of America.
Rahman NM; Oxford Respiratory Trials Unit, Oxford Centre for Respiratory Medicine, University of Oxford, Oxford, United Kingdom.; Oxford NIHR Biomedical Research Centre, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 May 08; Vol. 15 (5), pp. e0232181. Date of Electronic Publication: 2020 May 08 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Microbiota*
Pleural Effusion, Malignant/*microbiology
Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Pleural Effusion, Malignant/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interpreting pleural fluid results .
Autorzy:
Mercer RM; University of Oxford, Oxford, UK and Oxford University Hospitals NHS Trust, Oxford, UK .
Corcoran JP; University Hospitals Plymouth NHS Trust, Plymouth, UK.
Porcel JM; Arnau de Vilanova University Hospital, Lleida, Spain.
Rahman NM; University of Oxford, Oxford, UK and Oxford University Hospitals NHS Trust, Oxford, UK.
Psallidas I; University of Oxford, Oxford, UK and Oxford University Hospitals NHS Trust, Oxford, UK.
Pokaż więcej
Źródło:
Clinical medicine (London, England) [Clin Med (Lond)] 2019 May; Vol. 19 (3), pp. 213-217.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pleural Diseases/*diagnosis
Pleural Effusion/*diagnosis
Biomarkers/analysis ; Diagnosis, Differential ; Humans ; Pleural Diseases/pathology ; Pleural Effusion/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Recent developments in the management of pleural infection: A comprehensive review.
Autorzy:
Bedawi EO; Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, University of Oxford, Oxford, United Kingdom.
Hassan M; Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, University of Oxford, Oxford, United Kingdom.; Chest Diseases Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Rahman NM; Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2018 Aug; Vol. 12 (8), pp. 2309-2320.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Empyema, Pleural/*microbiology
Pleura/*microbiology
Pleural Effusion/*metabolism
Pleural Effusion/*microbiology
Cost of Illness ; Empyema, Pleural/epidemiology ; Empyema, Pleural/mortality ; Empyema, Pleural/pathology ; Gastrointestinal Microbiome/physiology ; Humans ; Incidence ; Pleura/diagnostic imaging ; Pleura/metabolism ; Pleura/surgery ; Thoracoscopy/methods ; Thrombolytic Therapy/methods ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft.
Autorzy:
Ismail R; Laboratory of Immunotherapeutic and Vaccines, Institute of Bioscience, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
Allaudin ZN; Laboratory of Immunotherapeutic and Vaccines, Institute of Bioscience, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. .; Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. .
Abdullah R; Department of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
Mohd Lila MA; Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
Nik Abd Rahman NM; Laboratory of Immunotherapeutic and Vaccines, Institute of Bioscience, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
Abdul Rahman SO; Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2016 Jul 13; Vol. 16, pp. 461. Date of Electronic Publication: 2016 Jul 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Therapy*/adverse effects
Apoptosis/*genetics
Basigin/*genetics
Capsid Proteins/*genetics
Colorectal Neoplasms/*therapy
Allografts/transplantation ; Animals ; Cell Line, Tumor ; Colorectal Neoplasms/genetics ; Combined Modality Therapy ; Female ; Flow Cytometry ; Humans ; In Situ Nick-End Labeling ; Mice ; Mice, Inbred BALB C ; Neoplasms, Experimental ; RNA Interference ; RNA, Small Interfering/genetics ; Transfection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Tuberculous pleuritis secondary to Mycobacterium bovis in a veterinarian.
Autorzy:
Corcoran JP; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, UK.
Hallifax RJ; University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, UK.
Bettinson HV; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.
Psallidas I; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, UK.
Rahman NM; Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.; University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, UK.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2016 Jul; Vol. 10 (4), pp. 500-3. Date of Electronic Publication: 2014 Nov 09.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Occupational Exposure*
Antitubercular Agents/*therapeutic use
Mycobacterium bovis/*isolation & purification
Tuberculosis, Bovine/*transmission
Tuberculosis, Pleural/*diagnosis
Tuberculosis, Pleural/*microbiology
Adult ; Animals ; Biopsy ; Cattle ; Humans ; Male ; Treatment Outcome ; Tuberculosis, Pleural/drug therapy ; Veterinarians ; Zoonoses/drug therapy ; Zoonoses/microbiology ; Zoonoses/transmission
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
Autorzy:
Mishra EK; Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.
Corcoran JP; Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.
Hallifax RJ; Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.
Stradling J; Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.
Maskell NA; University of Bristol, Bristol, United Kingdom.
Rahman NM; Oxford Centre for Respiratory Medicine and Oxford Respiratory Trials Unit, Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Apr 15; Vol. 10 (4), pp. e0123798. Date of Electronic Publication: 2015 Apr 15 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*surgery
Carcinoma, Non-Small-Cell Lung/*surgery
Dyspnea/*diagnosis
Dyspnea/*surgery
Mesothelioma/*surgery
Ovarian Neoplasms/*surgery
Pleural Effusion, Malignant/*surgery
Aged ; Breast Neoplasms/complications ; Breast Neoplasms/physiopathology ; Carcinoma, Non-Small-Cell Lung/complications ; Carcinoma, Non-Small-Cell Lung/physiopathology ; Drainage/methods ; Dyspnea/complications ; Dyspnea/physiopathology ; Female ; Humans ; Male ; Mesothelioma/complications ; Mesothelioma/physiopathology ; Middle Aged ; Ovarian Neoplasms/complications ; Ovarian Neoplasms/physiopathology ; Pleural Effusion, Malignant/complications ; Pleural Effusion, Malignant/physiopathology ; Severity of Illness Index ; Surveys and Questionnaires ; Visual Analog Scale
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial.
Autorzy:
Arnold DT; Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol BS10 5NB, UK.
Hooper CE; 1] Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol BS10 5NB, UK [2] North Bristol Lung Centre, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK.
Morley A; North Bristol Lung Centre, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK.
White P; Applied Statistics Group, University of West of England (UWE), Bristol BS16 1QY, UK.
Lyburn ID; Cobalt Health, Thirlestaine Road, Cheltenham GL53 7AS, UK.
Searle J; Cobalt Health, Thirlestaine Road, Cheltenham GL53 7AS, UK.
Darby M; Department of Radiology, Southmead Hopsital, North Bristol NHS Trust, Bristol BS10 5NB, UK.
Hall T; Department of Radiology, Royal United Hospital Bath, Bath BA1 3NG, UK.
Hall D; Cobalt Health, Thirlestaine Road, Cheltenham GL53 7AS, UK.
Rahman NM; Oxford Respiratory Clinical Trial Unit (Funded by the NIHR Biomedical Research Centre), Churchill Hospital, Oxford OX3 7LJ, UK.
De Winton E; Department of Oncology, Royal United Hospital Bath, Bath BA1 3NG, UK.
Clive A; Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol BS10 5NB, UK.
Masani V; Department of Respiratory Medicine, Royal United Hospital Bath, Bath BA1 3NG, UK.
Dangoor A; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8ED, UK.
Guglani S; Department of Oncology, Cheltenham General Hospital, Cheltenham GL53 7AN, UK.
Jankowska P; Department of Oncology, Musgrove Park Hospital, Taunton, Severn TA1 5DA, UK.
Lowndes SA; Department of Oncology, Great Western Hospital, Swindon SN3 6BB, UK.
Harvey JE; North Bristol Lung Centre, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK.
Braybrooke JP; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8ED, UK.
Maskell NA; 1] Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol BS10 5NB, UK [2] North Bristol Lung Centre, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2015 Mar 31; Vol. 112 (7), pp. 1183-9. Date of Electronic Publication: 2015 Mar 31.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lung Neoplasms/*drug therapy
Mesothelioma/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/analysis ; Carboplatin/administration & dosage ; Cisplatin/administration & dosage ; Female ; Glutamates/administration & dosage ; Guanine/administration & dosage ; Guanine/analogs & derivatives ; Humans ; Lung Neoplasms/pathology ; Male ; Mesothelioma/pathology ; Mesothelioma, Malignant ; Middle Aged ; Palliative Care ; Pemetrexed ; Prospective Studies ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 24

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies